Style | Citing Format |
---|---|
MLA | Hashemi B, et al.. "The Effect of Probiotics on Immune Responses and Their Therapeutic Application: A New Treatment Option for Multiple Sclerosis." Biomedicine and Pharmacotherapy, vol. 159, no. , 2023, pp. -. |
APA | Hashemi B, Abdollahi M, Abbaspouraghdam S, Hazrati A, Malekpour K, Meshgi S, Kafil HS, Ghazi F, Yousefi M, Roshangar L, Ahmadi M (2023). The Effect of Probiotics on Immune Responses and Their Therapeutic Application: A New Treatment Option for Multiple Sclerosis. Biomedicine and Pharmacotherapy, 159(), -. |
Chicago | Hashemi B, Abdollahi M, Abbaspouraghdam S, Hazrati A, Malekpour K, Meshgi S, Kafil HS, et al.. "The Effect of Probiotics on Immune Responses and Their Therapeutic Application: A New Treatment Option for Multiple Sclerosis." Biomedicine and Pharmacotherapy 159, no. (2023): -. |
Harvard | Hashemi B et al. (2023) 'The Effect of Probiotics on Immune Responses and Their Therapeutic Application: A New Treatment Option for Multiple Sclerosis', Biomedicine and Pharmacotherapy, 159(), pp. -. |
Vancouver | Hashemi B, Abdollahi M, Abbaspouraghdam S, Hazrati A, Malekpour K, Meshgi S, et al.. The Effect of Probiotics on Immune Responses and Their Therapeutic Application: A New Treatment Option for Multiple Sclerosis. Biomedicine and Pharmacotherapy. 2023;159():-. |
BibTex | @article{ author = {Hashemi B and Abdollahi M and Abbaspouraghdam S and Hazrati A and Malekpour K and Meshgi S and Kafil HS and Ghazi F and Yousefi M and Roshangar L and Ahmadi M}, title = {The Effect of Probiotics on Immune Responses and Their Therapeutic Application: A New Treatment Option for Multiple Sclerosis}, journal = {Biomedicine and Pharmacotherapy}, volume = {159}, number = {}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Hashemi B AU - Abdollahi M AU - Abbaspouraghdam S AU - Hazrati A AU - Malekpour K AU - Meshgi S AU - Kafil HS AU - Ghazi F AU - Yousefi M AU - Roshangar L AU - Ahmadi M TI - The Effect of Probiotics on Immune Responses and Their Therapeutic Application: A New Treatment Option for Multiple Sclerosis JO - Biomedicine and Pharmacotherapy VL - 159 IS - SP - EP - PY - 2023 ER - |